| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Sr. VP &CMO
1 company
Rottinghaus Scott T. is a Chief Medical Officer at ENANTA PHARMACEUTICALS INC. Recent SEC Form 4 filings include 0 buys and 6 sells.
Estimated insider holdings value: $334K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 5, 2025 | ENTA Enanta Pharmaceuticals Inc | Chief Medical Officer | Sell | 798 | $14.23 | $11,355.54 | -3.5% | -5.8% | - | |
| Dec 6, 2024 | ENTA Enanta Pharmaceuticals Inc | Chief Medical Officer | Sell | 866 | $8.06 | $6,979.96 | -4.6% | -10.3% | +82.5% | |
| Jul 15, 2024 | ENTA Enanta Pharmaceuticals Inc | Chief Medical Officer | Sale+OE | 11,945 | $15.97 | $190,746.77 | -15.1% | -31.6% | -60.2% | |
| Dec 5, 2023 | ENTA Enanta Pharmaceuticals Inc | Sr. VP &CMO | Sell | 534 | $9.63 | $5,142.42 | -2.0% | +65.3% | -9.9% |